XML 59 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020 70,176,046        
Beginning balance at Dec. 31, 2020 $ 331,966        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Issuance of convertible preferred shares (in shares) 4,174,551        
Issuance of convertible preferred shares $ 52,460        
Conversion of redeemable convertible preferred stock (in shares) (74,350,597)        
Conversion of redeemable convertible preferred stock $ (384,426)        
Ending balance (in shares) at Mar. 31, 2021 0        
Ending balance at Mar. 31, 2021 $ 0        
Beginning balance (in shares) at Dec. 31, 2020   20,591,554      
Beginning balance at Dec. 31, 2020 (39,599) $ 0 $ 5,607 $ (283) $ (44,923)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares upon initial public offering net of underwriting discounts, commissions and offering costs (in shares)   18,400,000      
Issuance of common shares upon initial public offering net of underwriting discounts, commissions and offering costs 339,174   339,174    
Conversion of redeemable convertible preferred stock (in shares)   89,220,699      
Conversion of redeemable convertible preferred stock 384,426   384,426    
Shares of common stock issued in connection with incentive stock plan (in shares)   530,870      
Shares of common stock issued in connection with inventive stock plan 1,438   1,438    
Stock-based compensation 2,812   2,812    
Net loss (23,128)       (23,128)
Other comprehensive income (loss) 30     30  
Ending balance (in shares) at Mar. 31, 2021   128,743,123      
Ending balance at Mar. 31, 2021 $ 665,153 $ 0 733,457 (253) (68,051)
Ending balance (in shares) at Mar. 31, 2022 0        
Beginning balance (in shares) at Dec. 31, 2021   129,028,278      
Beginning balance at Dec. 31, 2021 $ 555,199 $ 0 757,003 (87) (201,717)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Shares of common stock issued in connection with incentive stock plan (in shares)   189,638      
Shares of common stock issued in connection with incentive stock plan 338   338    
Stock-based compensation 7,493   7,493    
Net loss (54,117)       (54,117)
Other comprehensive income (loss) (354)     (354)  
Ending balance (in shares) at Mar. 31, 2022   129,217,916      
Ending balance at Mar. 31, 2022 $ 508,559 $ 0 $ 764,834 $ (441) $ (255,834)